Aging Section, Consiglio Nazionale delle Ricerche (CNR)-Institute of Neuroscience, Padua, Italy.
J Bone Miner Res. 2012 Nov;27(11):2271-8. doi: 10.1002/jbmr.1677.
Vitamin K (vitamin K1 or phylloquinone and vitamin K2, a series of menaquinones [MKs]) is involved in the production of bone and matrix amino acid γ-carboxy-glutamic acid (Gla) proteins, regulating bone and vascular calcification. Low vitamin K concentrations are associated with increased risks of fractures and vascular calcification, and frequent complications in hemodialysis patients. We carried out an observational study to establish the prevalence of vitamin K deficiency and to assess the relationship between vitamin K status, vertebral fractures, vascular calcification, and survival in 387 patients on hemodialysis for ≥1 year. We determined plasma levels of vitamin K compound, bone-Gla-protein, matrix-Gla-protein, and routine biochemistry. Vertebral fractures (reduction in vertebral body height by ≥20%) and aortic and iliac calcifications were also investigated in a spine (D(5) -L(4)) radiograph. Three-year patient survival was analyzed. Important proportions of patients had deficiency of MK7 (35.4%), vitamin K1 (23.5%), and MK4 (14.5%). A total of 55.3% of patients had vertebral fractures, 80.6% had abdominal aorta calcification, and 56.1% had iliac calcification. Vitamin K1 deficiency was the strongest predictor of vertebral fractures (odds ratio [OR], 2.94; 95% confidence interval [CI], 1.38-6.26). MK4 deficiency was a predictor of aortic calcification (OR, 2.82; 95% CI, 1.14-7.01), whereas MK5 deficiency actually protected against it (OR, 0.38; 95% CI, 0.15-0.95). MK7 deficiency was a predictor of iliac calcification (OR, 1.64; 95% CI, 1.03-2.60). The presence of vertebral fractures was also a predictor of vascular calcifications (OR, 1.76; 95% CI, 1.00-3.08). Increased alkaline phosphatase and C reactive protein (CRP), age, and cerebrovascular events were predictors of mortality. Our study suggests that the vitamin K system may be important for preserving bone mass and avoiding vascular calcification in hemodialysis patients, pointing out a possible role of vitamin K in bone and vascular health. Based on our results, we suggest that the general population should also be studied for vitamin K deficiency as a possible cause of both vertebral fractures and vascular calcification.
维生素 K(维生素 K1 或叶绿醌和维生素 K2,一系列的甲萘醌 [MKs])参与骨和基质氨基酸 γ-羧基-谷氨酸(Gla)蛋白的生成,调节骨和血管钙化。低维生素 K 浓度与骨折和血管钙化风险增加以及血液透析患者频繁并发症相关。我们进行了一项观察性研究,以确定维生素 K 缺乏的流行情况,并评估 387 名血液透析≥1 年的患者的维生素 K 状态、椎体骨折、血管钙化和生存之间的关系。我们测定了维生素 K 复合物、骨 Gla 蛋白、基质 Gla 蛋白和常规生化的血浆水平。还在脊柱(D5-L4)射线照片中检查了椎体骨折(椎体高度降低≥20%)和主动脉及髂动脉钙化。分析了 3 年患者生存率。重要比例的患者存在 MK7(35.4%)、维生素 K1(23.5%)和 MK4(14.5%)缺乏。55.3%的患者有椎体骨折,80.6%有腹主动脉钙化,56.1%有髂动脉钙化。维生素 K1 缺乏是椎体骨折的最强预测因子(比值比 [OR],2.94;95%置信区间 [CI],1.38-6.26)。MK4 缺乏是主动脉钙化的预测因子(OR,2.82;95%CI,1.14-7.01),而 MK5 缺乏实际上可预防其发生(OR,0.38;95%CI,0.15-0.95)。MK7 缺乏是髂动脉钙化的预测因子(OR,1.64;95%CI,1.03-2.60)。椎体骨折的存在也是血管钙化的预测因子(OR,1.76;95%CI,1.00-3.08)。碱性磷酸酶和 C 反应蛋白(CRP)升高、年龄和脑血管事件是死亡的预测因子。我们的研究表明,维生素 K 系统可能对维持血液透析患者的骨量和避免血管钙化很重要,提示维生素 K 在骨骼和血管健康中可能发挥作用。基于我们的结果,我们建议也应研究普通人群的维生素 K 缺乏症,因为它可能是椎体骨折和血管钙化的原因之一。